CURE.ASX
Global X S&P Biotech ETF
https://www.marketindex.com.au/asx/cure/financials
Annual Financial Summary
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
Profitability
NPAT ($)
6,785,000
(26,604,000)
-
-
-
-
-
NPAT Margin
--
--
-
-
-
-
-
Abnormals ($)
-
-
-
-
-
-
-
NPAT before Abnormals ($)
6,785,000
(26,604,000)
-
-
-
-
-
Return on Equity (ROE)
17.15%
-63.53%
-
-
-
-
-
Return on Assets (ROA)
17.15%
-63.46%
-
-
-
-
-
Valuation
PE Ratio
5.85
(1.57)
-
-
-
-
-
PE Relative to Market
38.0%
0.0%
-
-
-
-
-
Price to Book
1.00
1.00
-
-
-
-
-
Price to Cash Flow
8.36
(2.24)
-
-
-
-
-
Shares Outstanding (M)
0.92
1.13
-
-
-
-
-
Market Cap ($M)
$39.70
$41.80
-
-
-
-
-
Enterprise Value ($M)
$39.65
$41.72
-
-
-
-
-
Performance
Total Shareholder Return
16.6%
-40.5%
-
-
-
-
-
Relative to Market
1.8%
-33.1%
-
-
-
-
-
Per Share
Earnings (EPS Adjusted)
734.31
-2,346.03
-
-
-
-
-
Earnings (with Abnormals)
734.31
-2,346.03
-
-
-
-
-
Cash Flow
975.00
(1,221.00)
-
-
-
-
-
Cash
0.05
0.07
-
-
-
-
-
Net Tangible Assets
42.81
36.93
-
-
-
-
-
Book Value
42.81
36.93
-
-
-
-
-
Share Price
$42.96
$36.86
-
-
-
-
-
Liquidity
Quick Ratio
3.47
2.00
-
-
-
-
-
Current Ratio
3.47
2.00
-
-
-
-
-
Efficiency
Asset Turnover
0.00
0.00
-
-
-
-
-
Inventory Turnover
-
-
-
-
-
-
-
Working Capital Turnover
0.00
0.00
-
-
-
-
-
Dividends
DPS (c)
-
2.40
-
-
-
-
-
Dividend yield
-
-
-
-
-
-
-
Franking
-
-
-
-
-
-
-
Gross DPS (c)
-
2.40
-
-
-
-
-
Gross Dividend Yield
-
-
-
-
-
-
-
Payout Ratio
-
-
-
-
-
-
-
Member Content
Source:
Annual Financial Income Statement
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
Revenue from Operations
Investment Income
(5,448,000)
(14,662,000)
-
-
-
-
-
Other Income
2,000
2,000
-
-
-
-
-
Expenses
(225,000)
(270,000)
-
-
-
-
-
Profit / Loss before income tax
6,785,000
(26,604,000)
-
-
-
-
-
Tax Expense
-
-
-
-
-
-
-
NPAT before Abnormals
6,785,000
(26,604,000)
-
-
-
-
-
Abnormals
-
-
-
-
-
-
-
Abnormals Tax
-
-
-
-
-
-
-
Net Abnormals
-
-
-
-
-
-
-
Outside Equity
-
-
-
-
-
-
-
Preference Dividends
-
-
-
-
-
-
-
Reported NPAT after Abnormals
6,785,000
(26,604,000)
-
-
-
-
-
EQUITY
Share End
924,000
1,134,000
-
-
-
-
-
Share Weighted
924,000
1,134,000
-
-
-
-
-
Ordinary Dividends
-
(27,000)
-
-
-
-
-
EPS Adjusted
7,343,100
(23,460,300)
-
-
-
-
-
EPS after Abs
7,343,074
(23,460,317)
-
-
-
-
-
Equity Profit / Loss
-
-
-
-
-
-
-
Member Content
Source:
Annual Financial Balance Sheet
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
CURRENT ASSETS
Cash and Cash Equivalents
0.04
0.08
-
-
-
-
-
Receivables
0.02
0.01
-
-
-
-
-
Investments
-
-
-
-
-
-
-
Other Current Assets
-
-
-
-
-
-
-
Total Current Assets
0.06
0.09
-
-
-
-
-
NON-CURRENT ASSETS
Investments
39.52
41.83
-
-
-
-
-
Property
-
-
-
-
-
-
-
Other Non-Current Assets
-
-
-
-
-
-
-
Total Non-Current Assets
39.52
41.83
-
-
-
-
-
TOTAL ASSETS
39.57
41.92
-
-
-
-
-
CURRENT LIABILITIES
Creditors
0.02
0.02
-
-
-
-
-
Provisions
-
0.03
-
-
-
-
-
Other Liabilities
-
-
-
-
-
-
-
TOTAL CURRENT LIABILITIES
0.02
0.04
-
-
-
-
-
NON-CURRENT LIABILITIES
Borrowings
-
-
-
-
-
-
-
Deferred Tax
-
-
-
-
-
-
-
Other Non-Current Liabilities
-
-
-
-
-
-
-
TOTAL NON-CURRENT LIABILITIES
-
-
-
-
-
-
-
TOTAL LIABILITIES
0.02
0.04
-
-
-
-
-
NET ASSETS
39.59
41.96
-
-
-
-
-
Total Equity Attr. to Holders
39.56
41.88
-
-
-
-
-
Outside Equity
-
-
-
-
-
-
-
TOTAL EQUITY
39.56
41.88
-
-
-
-
-
Member Content
Source:
Annual Financial Cash Flow
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
N/A
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
39.93
40.3
-
-
-
-
-
Payments
(30.95)
(54.15)
-
-
-
-
-
Funds from Operations
-
-
-
-
-
-
-
Dividends Received
0.04
0.04
-
-
-
-
-
Interest Received
-
-
-
-
-
-
-
Interest Paid
-
-
-
-
-
-
-
Tax Paid
-
-
-
-
-
-
-
Other Operating Cash
(0.02)
(0.03)
-
-
-
-
-
NET CASH FROM OPERATING ACTIVITIES
9.01
(13.85)
-
-
-
-
-
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
-
-
-
-
-
Payments
-
-
-
-
-
-
-
PP&E
-
-
-
-
-
-
-
Proceeds PP&E
-
-
-
-
-
-
-
Purchase Subsidiary
-
-
-
-
-
-
-
Proceeds Subsidiary
-
-
-
-
-
-
-
Loans Granted
-
-
-
-
-
-
-
Loans Repaid
-
-
-
-
-
-
-
Other Investing Cash
-
-
-
-
-
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
-
-
-
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
1.68
18.17
-
-
-
-
-
Proceeds from Borrowings
-
-
-
-
-
-
-
Borrowings
-
-
-
-
-
-
-
Dividends Paid
(0.02)
(4.4)
-
-
-
-
-
Other Financing Cash
(10.79)
(1.31)
-
-
-
-
-
NET CASH FROM FINANCING ACTIVITIES
(9.13)
12.46
-
-
-
-
-
NET CHANGE IN CASH
(0.12)
(1.38)
-
-
-
-
-
CASH AT START
0.08
1.43
-
-
-
-
-
Exchange Rate Adjustment
0.09
0.02
-
-
-
-
-
Other Cash Adjustment
-
-
-
-
-
-
-
CASH AT END
0.04
0.08
-
-
-
-
-
Member Content
Source: